Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.
2.

Marked elevation of adrenal steroids, especially androgens, in saliva of prepubertal autistic children.

Majewska MD, Hill M, Urbanowicz E, Rok-Bujko P, Bieńkowski P, Namysłowska I, Mierzejewski P.

Eur Child Adolesc Psychiatry. 2014 Jun;23(6):485-98. doi: 10.1007/s00787-013-0472-0. Epub 2013 Sep 17.

3.
4.

Krakow's children and cognitive function: can the study by Jedrychowski et al. show us the bigger picture?

Majewska MD, Dórea JG.

Eur J Pediatr. 2012 Feb;171(2):405; author reply 407. doi: 10.1007/s00431-011-1612-5. Epub 2011 Oct 22. No abstract available.

5.

Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate.

Duszczyk-Budhathoki M, Olczak M, Lehner M, Majewska MD.

Neurochem Res. 2012 Feb;37(2):436-47. doi: 10.1007/s11064-011-0630-z. Epub 2011 Oct 21.

6.

Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats.

Olczak M, Duszczyk M, Mierzejewski P, Meyza K, Majewska MD.

Behav Brain Res. 2011 Sep 30;223(1):107-18. doi: 10.1016/j.bbr.2011.04.026. Epub 2011 Apr 28.

PMID:
21549155
7.

Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal.

Olczak M, Duszczyk M, Mierzejewski P, Wierzba-Bobrowicz T, Majewska MD.

Folia Neuropathol. 2010;48(4):258-69.

8.
9.

Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

Olczak M, Duszczyk M, Mierzejewski P, Bobrowicz T, Majewska MD.

Neurochem Res. 2010 Nov;35(11):1840-7. doi: 10.1007/s11064-010-0250-z. Epub 2010 Aug 28.

10.

Age-dependent lower or higher levels of hair mercury in autistic children than in healthy controls.

Majewska MD, Urbanowicz E, Rok-Bujko P, Namyslowska I, Mierzejewski P.

Acta Neurobiol Exp (Wars). 2010;70(2):196-208.

11.

Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats.

Olczak M, Duszczyk M, Mierzejewski P, Majewska MD.

Brain Res. 2009 Dec 8;1301:143-51. doi: 10.1016/j.brainres.2009.09.003. Epub 2009 Sep 9.

PMID:
19747466
13.

Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST).

Shoptaw S, Watson DW, Reiber C, Rawson RA, Montgomery MA, Majewska MD, Ling W.

Addiction. 2005 Mar;100 Suppl 1:78-90.

PMID:
15730352
14.

DHEAS and POMS measures identify cocaine dependence treatment outcome.

Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D, Setoda D.

Psychoneuroendocrinology. 2005 Jan;30(1):18-28.

PMID:
15358439
15.

Participants receiving dehydroepiandrosterone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study.

Shoptaw S, Majewska MD, Wilkins J, Twitchell G, Yang X, Ling W.

Exp Clin Psychopharmacol. 2004 May;12(2):126-35.

PMID:
15122957
16.

A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence.

Kampman K, Majewska MD, Tourian K, Dackis C, Cornish J, Poole S, O'Brien C.

Addict Behav. 2003 Apr;28(3):437-48.

PMID:
12628617
17.

HPA axis and stimulant dependence: an enigmatic relationship.

Majewska MD.

Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):5-12. Review.

PMID:
11750767
18.

Neurotoxicity and neuropathology associated with chronic cocaine abuse.

Majewska MD.

NIDA Res Monogr. 1996;162:70-2. No abstract available.

PMID:
9066818
19.

Cocaine addiction as a neurological disorder: implications for treatment.

Majewska MD.

NIDA Res Monogr. 1996;163:1-26. Review.

PMID:
8809851
20.

Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect.

Majewska MD.

Ann N Y Acad Sci. 1995 Dec 29;774:111-20. Review. No abstract available.

PMID:
8597451

Supplemental Content

Loading ...
Support Center